Description
A GAPDH ligand; binds to purified recombinant rabbit muscle GAPDH using affinity purification; increases survival of trophically withdrawn PC12 cells, dose-dependently decreases cytosine arabinoside-induced apoptosis of cerebellar granule cells, and increases the number of TH+ mesencephalic dopaminergic neurons in vitro; increases the number of TH+ dopaminergic neurons in an MPTP-induced rat model of Parkinson’s disease; reduces delayed acquisition in the Morris maze in a 6-OHDA-treated rat model of Parkinson’s disease; increases survival in pmn mice
Formal name: N-methyl-N-2-propyn-1-yl-dibenz[b,f]oxepin-10-methanamine, (2Z)-2-butenedioate
Synonyms: CGP 3466B
Molecular weight: 391.4
CAS: 200189-97-5
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals||Research Area|Cell Biology|Cell Death|Apoptosis||Research Area|Neuroscience|Behavioral Neuroscience|Learning & Memory||Research Area|Neuroscience|Neurodegenerative Disorders|Parkinson’s Disease